The efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in patients with metastatic non-small cell lung cancer harboring sensitizing EGFR mutations.
Patil T, Gao D, Watson A, Sakamoto M, Nie Y, Gibson A, Dean ML, Yoder BA, Miller E, Stalker M, Aisner DL, Bunn PA, Schenk EL, Marmarelis ME, Bennati C, Navani V, Zhang Y, Camidge DR.
Patil T, et al. Among authors: dean ml.
Lung Cancer. 2024 Nov 25;199:108040. doi: 10.1016/j.lungcan.2024.108040. Online ahead of print.
Lung Cancer. 2024.
PMID: 39615411
Free article.